β-Amyloid: The key peptide in the pathogenesis of Alzheimer's disease

Frontiers in Pharmacology

Volumn 6, Issue SEP, 2015, Pages

  Sun, Xiaojuan ^a   Chen, Wei Dong ^a   Wang, Yan Dong ^b  

^a HENAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid peptide; Animal models; Biogenesis

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BAPINEUZUMAB; BETA SECRETASE; GAMMA SECRETASE; REACTIVE OXYGEN METABOLITE; SOLANEZUMAB;

ALZHEIMER DISEASE; DISEASE COURSE; DRUG TARGETING; DRUG TREATMENT FAILURE; ENZYME INHIBITION; EXPERIMENTAL ANIMAL; HUMAN; IMMUNOTHERAPY; MICROGLIA; MITOCHONDRIAL DYNAMICS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGULATORY MECHANISM; SHORT SURVEY;

EID: 84944750508     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00221     Document Type: Short Survey

References (114)

1. Agca, C., Fritz, J. J., Walker, L. C., Levey, A. I., Chan, A. W., Lah, J. J., et al. (2008). Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically. BMC Neurosci. 9:28. doi: 10.1186/1471-2202-9-28
2. Aksenov, M., Aksenova, M. V., Harris, M. E., Hensley, K., Butterfield, D. A., and Carney, J. M. (1995). Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase. J. Neurochem. 65, 1899-1902. doi: 10.1046/j.1471-4159.1995.65041899.x
3. Alzheimer's, A. (2014). 2014 Alzheimer's disease facts and figures. Alzheimers Dement. 10, e47-e92. doi: 10.1016/j.jalz.2014.02.001
4. Alzheimer's, A. (2015). 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 11, 332-384. doi: 10.1016/j.jalz.2015.02.003
5. Anandatheerthavarada, H. K., Biswas, G., Robin, M. A., and Avadhani, N. G. (2003). Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41-54. doi: 10.1083/jcb.200207030
6. Arslanova, D., Yang, T., Xu, X., Wong, S. T., Augelli-Szafran, C. E., and Xia, W. (2010). Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol. 10:24. doi: 10.1186/1472-6750-10-24
7. Baranello, R. J., Bharani, K. L., Padmaraju, V., Chopra, N., Lahiri, D. K., Greig, N. H., et al. (2015). Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. Curr. Alzheimer Res. 12, 32-46. doi: 10.2174/1567205012666141218140953
8. Barsoum, M. J., Yuan, H., Gerencser, A. A., Liot, G., Kushnareva, Y., Graber, S., et al. (2006). Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25, 3900-3911. doi: 10.1038/sj.emboj.7601253
9. Baruch, K., Rosenzweig, N., Kertser, A., Deczkowska, A., Sharif, A. M., Spinrad, A., et al. (2015). Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat. Commun. 6, 7967. doi: 10.1038/ncomms8967
10. Ben Khalifa, N., Tyteca, D., Marinangeli, C., Depuydt, M., Collet, J. F., Courtoy, P. J., et al. (2012). Structural features of the KPI domain control APP dimerization, trafficking, and processing. FASEB J. 26, 855-867. doi: 10.1096/fj.11-190207
11. Bhalla, A., Vetanovetz, C. P., Morel, E., Chamoun, Z., Di Paolo, G., and Small, S. A. (2012). The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiol. Dis. 47, 126-134. doi: 10.1016/j.nbd.2012.03.030
12. Bordji, K., Becerril-Ortega, J., Nicole, O., and Buisson, A. (2010). Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ss production. J. Neurosci. 30, 15927-15942.
13. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., et al. (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
14. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., et al. (1998). Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767. doi: 10.1074/jbc.273.43.27765
15. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., et al. (2001). BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233-234. doi: 10.1038/85064
16. Carey, R. M., Balcz, B. A., Lopez-Coviella, I., and Slack, B. E. (2005). Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol. 6:30. doi: 10.1186/1471-2121-6-30
17. Carvalho, K. M., Franca, M. S., Camarao, G. C., and Ruchon, A. F. (1997). A new brain metalloendopeptidase which degrades the Alzheimer beta-amyloid 1-40 peptide producing soluble fragments without neurotoxic effects. Braz. J. Med. Biol. Res. 30, 1153-1156.
18. Caster, A. H., and Kahn, R. A. (2013). Recruitment of the Mint3 adaptor is necessary for export of the amyloid precursor protein (APP) from the Golgi complex. J. Biol. Chem. 288, 28567-28580. doi: 10.1074/jbc.M113.481101
19. Chartier-Harlin, M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., et al. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844-846. doi: 10.1038/353844a0
20. Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922. doi: 10.1016/j.neuron.2005.10.028
21. Clarke, J., Thornell, A., Corbett, D., Soininen, H., Hiltunen, M., and Jolkkonen, J. (2007). Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. Eur. J. Neurosci. 26, 1845-1852. doi: 10.1111/j.1460-9568.2007.05807.x
22. Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F. A., et al. (2005). Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132, 123-135. doi: 10.1016/j.neuroscience.2004.12.025
23. de Moura, M. B., dos Santos, L. S., and Van Houten, B. (2010). Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen. 51, 391-405. doi: 10.1002/em.20575
24. De Strooper, B. (2003). Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38, 9-12.
25. Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., and Anandatheerthavarada, H. K. (2006). Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26, 9057-9068. doi: 10.1523/JNEUROSCI.1469-06.2006
26. Do Carmo, S., and Cuello, A. C. (2013). Modeling Alzheimer's disease in transgenic rats. Mol. Neurodegener. 8, 37. doi: 10.1186/1750-1326-8-37
27. Doody, R. S., Farlow, M., Aisen, P. S., Alzheimer's Disease Cooperative Study Data, A., and Publication, C. (2014a). Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N. Engl. J. Med. 370, 1460. doi: 10.1056/NEJMoa1312889
28. Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., et al. (2014b). Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N. Engl. J. Med. 370, 311-321. doi: 10.1056/NEJMoa1312889
29. Dugan, J. M., deWit, C., McConlogue, L., and Maltese, W. A. (1995). The Ras-related GTP-binding protein, Rab1B, regulates early steps in exocytic transport and processing of beta-amyloid precursor protein. J. Biol. Chem. 270, 10982-10989. doi: 10.1074/jbc.270.18.10982
30. Eckman, E. A., Watson, M., Marlow, L., Sambamurti, K., and Eckman, C. B. (2003). Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J. Biol. Chem. 278, 2081-2084. doi: 10.1074/jbc.C200642200
31. Elder, G. A., Gama Sosa, M. A., and De Gasperi, R. (2010). Transgenic mouse models of Alzheimer's disease. Mt. Sinai J. Med. N. Y. 77, 69-81. doi: 10.1002/msj.20159
32. Ezeani, M., and Omabe, M. (2015). A new perspective of lysosomal cation channel-dependent homeostasis in Alzheimer's disease. Mol. Neurobiol. doi: 10.1007/s12035-015-9108-3 [Epub ahead of print].
33. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., et al. (2003). Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U.S.A. 100, 4162-4167. doi: 10.1073/pnas.0230450100
34. Finelli, A., Kelkar, A., Song, H. J., Yang, H., and Konsolaki, M. (2004). A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Mol. Cell. Neurosci. 26, 365-375. doi: 10.1016/j.mcn.2004.03.001
35. Gandy, S., Caporaso, G., Buxbaum, J., Frangione, B., and Greengard, P. (1994). APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging 15, 253-256.
36. Glabe, C. C. (2005). Amyloid accumulation and pathogensis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar Abeta. Subcell. Biochem. 38, 167-177. doi: 10.1007/0-387-23226-5_8
37. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706. doi: 10.1038/349704a0
38. Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J., and Younkin, S. G. (1992). Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728-730. doi: 10.1126/science.1738847
39. Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L. Jr., Younkin, L. H., et al. (1995). Amyloid beta protein. (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J. Biol. Chem. 270, 7013-7016.
40. Greenfield, J. P., Tsai, J., Gouras, G. K., Hai, B., Thinakaran, G., Checler, F., et al. (1999). Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 96, 742-747. doi: 10.1073/pnas.96.2.742
41. Greeve, I., Kretzschmar, D., Tschape, J. A., Beyn, A., Brellinger, C., Schweizer, M., et al. (2004). Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J. Neurosci. 24, 3899-3906. doi: 10.1523/JNEUROSCI.0283-04.2004
42. Hamazaki, H. (1996). Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein. FEBS Lett. 396, 139-142. doi: 10.1016/0014-5793(96)01087-3
43. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
44. Harkany, T., O'Mahony, S., Keijser, J., Kelly, J. P., Konya, C., Borostyankoi, Z. A., et al. (2001). Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiol. Dis. 8, 667-678. doi: 10.1006/nbdi.2001.0398
45. Harold, D., Jehu, L., Turic, D., Hollingworth, P., Moore, P., Summerhayes, P., et al. (2007). Interaction between the ADAM12 and SH3MD1 genes may confer susceptibility to late-onset Alzheimer's disease. Am. J. Med. Genet. 144B, 448-452. doi: 10.1002/ajmg.b.30456
46. Hartmann, T., Bieger, S. C., Bruhl, B., Tienari, P. J., Ida, N., Allsop, D., et al. (1997). Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat. Med. 3, 1016-1020. doi: 10.1038/nm0997-1016
47. He, G., Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., et al. (2010). Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 467, 95-98. doi: 10.1038/nature09325
48. Hemming, M. L., and Selkoe, D. J. (2005). Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J. Biol. Chem. 280, 37644-37650. doi: 10.1074/jbc.M508460200
49. Heneka, M. T., Golenbock, D. T., and Latz, E. (2015). Innate immunity in Alzheimer's disease. Nat. Immunol. 16, 229-236. doi: 10.1038/ni.3102
50. Huber, L. A., Pimplikar, S., Parton, R. G., Virta, H., Zerial, M., and Simons, K. (1993). Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane. J. Cell Biol. 123, 35-45. doi: 10.1083/jcb.123.1.35
51. Iijima, K., Chiang, H. C., Hearn, S. A., Hakker, I., Gatt, A., Shenton, C., et al. (2008). Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE 3:e1703. doi: 10.1371/journal.pone.0001703
52. Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., et al. (2001). Metabolic regulation of brain Abeta by neprilysin. Science 292, 1550-1552. doi: 10.1126/science.1059946
53. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., et al. (2003). APP processing and synaptic function. Neuron 37, 925-937. doi: 10.1016/S0896-6273(03)00124-7
54. Kanekiyo, T., and Bu, G. (2014). The low-density lipoprotein receptor-related protein 1 and amyloid-beta clearance in Alzheimer's disease. Front. Aging Neurosci. 6:93. doi: 10.3389/fnagi.2014.00093
55. Kanekiyo, T., Zhang, J., Liu, Q., Liu, C. C., Zhang, L., and Bu, G. (2011). Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J. Neurosci. 31, 1644-1651. doi: 10.1523/JNEUROSCI.5491-10.2011
56. Kang, J., and Muller-Hill, B. (1990). Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: preA4(695) mRNA is predominantly produced in rat and human brain. Biochem. Biophys. Res. Commun. 166, 1192-1200. doi: 10.1016/0006-291X(90)90992-V
57. Karran, E., Mercken, M., and De Strooper, B. (2011). The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. 10, 698-712. doi: 10.1038/nrd3505
58. Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., et al. (2007). Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633. doi: 10.1523/JNEUROSCI.4849-06.2007
59. Kim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., et al. (2009). Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet. 18, 3987-3996. doi: 10.1093/hmg/ddp323
60. King, J. V., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., and Tang, W. J. (2014). Molecular basis of substrate recognition and degradation by human presequence protease. Structure 22, 996-1007. doi: 10.1016/j.str.2014.05.003
61. Koike, H., Tomioka, S., Sorimachi, H., Saido, T. C., Maruyama, K., Okuyama, A., et al. (1999). Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343(Pt 2), 371-375. doi: 10.1042/0264-6021:3430371
62. Koo, E. H., and Squazzo, S. L. (1994). Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
63. Ledesma, M. D., Da Silva, J. S., Crassaerts, K., Delacourte, A., De Strooper, B., and Dotti, C. G. (2000). Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep. 1, 530-535. doi: 10.1093/embo-reports/kvd107
64. Lee, J., Retamal, C., Cuitino, L., Caruano-Yzermans, A., Shin, J. E., van Kerkhof, P., et al. (2008). Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes. J. Biol. Chem. 283, 11501-11508. doi: 10.1074/jbc.M800642200
65. Leon, W. C., Canneva, F., Partridge, V., Allard, S., Ferretti, M. T., DeWilde, A., et al. (2010). A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. J. Alzheimers Dis. 0, 113-126. doi: 10.3233/JAD-2010-1349
66. Li, J., Kanekiyo, T., Shinohara, M., Zhang, Y., LaDu, M. J., Xu, H., et al. (2012). Differential regulation of amyloid-beta endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J. Biol. Chem. 287, 44593-44601. doi: 10.1074/jbc.M112.420224
67. Li, Y., Marzolo, M. P., van Kerkhof, P., Strous, G. J., and Bu, G. (2000). The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein. J. Biol. Chem. 275, 17187-17194. doi: 10.1074/jbc.M000490200
68. Lim, J. Y., Ott, S., and Crowther, D. C. (2016). Drosophila melanogaster as a model for studies on the early stages of Alzheimer's disease. Methods Mol. Biol. 1303, 227-239. doi: 10.1007/978-1-4939-2627-5_13
69. Link, C. D. (2006). C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease. Exp. Gerontol. 41, 1007-1013. doi: 10.1016/j.exger.2006.06.059
70. Liu, S., Liu, Y., Hao, W., Wolf, L., Kiliaan, A. J., Penke, B., et al. (2012). TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation. J. Immunol. 188, 1098-1107. doi: 10.4049/jimmunol.1101121
71. Lublin, A. L., and Link, C. D. (2013). Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for beta-amyloid peptide-induced toxicity. Drug Discov. Today Technol. 10, e115-e119. doi: 10.1016/j.ddtec.2012.02.002
72. Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., et al. (2004). ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452. doi: 10.1126/science.1091230
73. Mark, R. J., Hensley, K., Butterfield, D. A., and Mattson, M. P. (1995). Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
74. Mattson, M. P. (2004). Pathways towards and away from Alzheimer's disease. Nature 430, 631-639. doi: 10.1038/nature02621
75. McConlogue, L., Castellano, F., deWit, C., Schenk, D., and Maltese, W. A. (1996). Differential effects of a Rab6 mutant on secretory versus amyloidogenic processing of Alzheimer's beta-amyloid precursor protein. J. Biol. Chem. 271, 1343-1348. doi: 10.1074/jbc.271.3.1343
76. Menendez-Gonzalez, M., Perez-Pinera, P., Martinez-Rivera, M., Calatayud, M. T., and Blazquez Menes, B. (2005). APP processing and the APP-KPI domain involvement in the amyloid cascade. Neurodegener. Dis. 2, 277-283. doi: 10.1159/000092315
77. Mueller-Steiner, S., Zhou, Y., Arai, H., Roberson, E. D., Sun, B., Chen, J., et al. (2006). Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51, 703-714. doi: 10.1016/j.neuron.2006.07.027
78. Muirhead, K. E., Borger, E., Aitken, L., Conway, S. J., and Gunn-Moore, F. J. (2010). The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease. Biochem. J. 426, 255-270. doi: 10.1042/BJ20091941
79. Musiek, E. S., and Holtzman, D. M. (2015). Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat. Neurosci. 18, 800-806. doi: 10.1038/nn.4018
80. Nag, S., Yee, B. K., and Tang, F. (1999). Chronic intracerebroventricular infusion of beta-amyloid (1-40) results in a selective loss of neuropeptides in addition to a reduction in choline acetyltransferase activity in the cortical mantle and hippocampus in the rat. Ann. N. Y. Acad. Sci. 897, 420-422. doi: 10.1111/j.1749-6632.1999.tb07911.x
81. Nakamura, S., Murayama, N., Noshita, T., Annoura, H., and Ohno, T. (2001). Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res. 912, 128-136. doi: 10.1016/S0006-8993(01)02704-4
82. Neniskyte, U., Neher, J. J., and Brown, G. C. (2011). Neuronal death induced by nanomolar amyloid beta is mediated by primary phagocytosis of neurons by microglia. J. Biol. Chem. 286, 39904-39913. doi: 10.1074/jbc.M111.267583
83. Nixon, R. A. (2007). Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 120, 4081-4091. doi: 10.1242/jcs.019265
84. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., et al. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140. doi: 10.1523/JNEUROSCI.1202-06.2006
85. Perez, R. G., Soriano, S., Hayes, J. D., Ostaszewski, B., Xia, W., Selkoe, D. J., et al. (1999). Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J. Biol. Chem. 274, 18851-18856. doi: 10.1074/jbc.274.27.18851
86. Rohan de Silva, H. A., Jen, A., Wickenden, C., Jen, L. S., Wilkinson, S. L., and Patel, A. J. (1997). Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes. Brain Res. Mol. Brain Res. 47, 147-156. doi: 10.1016/S0169-328X(97)00045-4
87. Rosen, R. F., Fritz, J. J., Dooyema, J., Cintron, A. F., Hamaguchi, T., Lah, J. J., et al. (2012). Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats. J. Neurochem. 120, 660-666. doi: 10.1111/j.1471-4159.2011.07551.x
88. Sahlin, C., Pettersson, F. E., Nilsson, L. N., Lannfelt, L., and Johansson, A. S. (2007). Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease. Eur. J. Neurosci. 26, 882-889. doi: 10.1111/j.1460-9568.2007.05719.x
89. Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., et al. (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N. Engl. J. Med. 370, 322-333. doi: 10.1056/NEJMoa1304839
90. Saporito-Irwin, S. M., and Van Nostrand, W. E. (1995). Coagulation factor XIa cleaves the RHDS sequence and abolishes the cell adhesive properties of the amyloid beta-protein. J. Biol. Chem. 270, 26265-26269. doi: 10.1074/jbc.270.44.26265
91. Schobel, S., Neumann, S., Hertweck, M., Dislich, B., Kuhn, P. H., Kremmer, E., et al. (2008). A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein. J. Biol. Chem. 283, 14257-14268. doi: 10.1074/jbc.M801531200
92. Sisodia, S. S. (1992). Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. U.S.A. 89, 6075-6079. doi: 10.1073/pnas.89.13.6075
93. Small, D. H., Mok, S. S., and Bornstein, J. C. (2001). Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 2, 595-598. doi: 10.1038/35086072
94. Tanabe, C., Hotoda, N., Sasagawa, N., Sehara-Fujisawa, A., Maruyama, K., and Ishiura, S. (2007). ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells. Biochem. Biophys. Res. Commun. 352, 111-117. doi: 10.1016/j.bbrc.2006.10.181
95. Taylor, D. R., and Hooper, N. M. (2007). The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J. 402, 17-23. doi: 10.1042/BJ20061736
96. Thathiah, A., Spittaels, K., Hoffmann, M., Staes, M., Cohen, A., Horre, K., et al. (2009). The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science 323, 946-951. doi: 10.1126/science.1160649
97. Thyrock, A., Ossendorf, E., Stehling, M., Kail, M., Kurtz, T., Pohlentz, G., et al. (2013). A new Mint1 isoform, but not the conventional Mint1, interacts with the small GTPase Rab6. PLoS ONE 8:e64149. doi: 10.1371/journal.pone.0064149
98. Tucker, H. M., Kihiko-Ehmann, M., and Estus, S. (2002). Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen. J. Neurosci. Res. 70, 249-255. doi: 10.1002/jnr.10417
99. Udayar, V., Buggia-Prevot, V., Guerreiro, R. L., Siegel, G., Rambabu, N., Soohoo, A. L., et al. (2013). A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of beta-amyloid production. Cell Rep. 5, 1536-1551. doi: 10.1016/j.celrep.2013.12.005
100. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D. A. (2000). Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130, 184-208. doi: 10.1006/jsbi.2000.4274
101. Wahle, T., Thal, D. R., Sastre, M., Rentmeister, A., Bogdanovic, N., Famulok, M., et al. (2006). GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide. J. Neurosci. 26, 12838-12846. doi: 10.1523/JNEUROSCI.1982-06.2006
102. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. doi: 10.1038/416535a
103. Walsh, D. M., and Selkoe, D. J. (2007). A beta oligomers-a decade of discovery. J. Neurochem. 101, 1172-1184. doi: 10.1111/j.1471-4159.2006.04426.x
104. Wang, B., Yang, W., Wen, W., Sun, J., Su, B., Liu, B., et al. (2010). Gamma-secretase gene mutations in familial acne inversa. Science 330, 1065. doi: 10.1126/science.1196284
105. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., et al. (2001). A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212-216. doi: 10.1038/35102591
106. Wen, L., Tang, F. L., Hong, Y., Luo, S. W., Wang, C. L., He, W., et al. (2011). VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J. Cell Biol. 195, 765-779. doi: 10.1083/jcb.201105109
107. Wu, Y., Wu, Z., Butko, P., Christen, Y., Lambert, M. P., Klein, W. L., et al. (2006). Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J. Neurosci. 26, 13102-13113. doi: 10.1523/JNEUROSCI.3448-06.2006
108. Xu, H., Sweeney, D., Wang, R., Thinakaran, G., Lo, A. C., Sisodia, S. S., et al. (1997). Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl. Acad. Sci. U.S.A. 94, 3748-3752. doi: 10.1073/pnas.94.8.3748
109. Yamada, T., Miyazaki, K., Koshikawa, N., Takahashi, M., Akatsu, H., and Yamamoto, T. (1995). Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells. Acta Neuropathol. 89, 199-203. doi: 10.1007/BF00309334
110. Yatin, S. M., Aksenov, M., and Butterfield, D. A. (1999). The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 24, 427-435. doi: 10.1023/A:1020997903147
111. Ye, Y., and Fortini, M. E. (1999). Apoptotic activities of wild-type and Alzheimer's disease-related mutant presenilins in Drosophila melanogaster. J. Cell Biol. 146, 1351-1364. doi: 10.1083/jcb.146.6.1351
112. Yu, W. H., Kumar, A., Peterhoff, C., Shapiro Kulnane, L., Uchiyama, Y., Lamb, B. T., et al. (2004). Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int. J. Biochem. Cell Biol. 36, 2531-2540. doi: 10.1016/j.biocel.2004.05.010
113. Zhou, S., Zhou, H., Walian, P. J., and Jap, B. K. (2005). CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Proc. Natl. Acad. Sci. U.S.A. 102, 7499-7504. doi: 10.1073/pnas.0502768102
114. Zhu, N., Lin, J., Wang, K., Wei, M., Chen, Q., and Wang, Y. (2015). Huperzine A protects neural stem cells against Abeta-induced apoptosis in a neural stem cells and microglia co-culture system. Int. J. Clin. Exp. Pathol. 8, 6425-6433.